October 2, 2013 — Proton therapy is the most advanced radiation technique available. Unfortunately, access to proton therapy is limited due to the low number of proton therapy centers. Research institutes and hospitals are now frequently investing in proton therapy to make it more accessible to patients.
According to the "US Proton Therapy Outlook 2017" by RNCOS, the United States will be home to almost 27 proton therapy centers by 2017, almost double the current figure, and attain revenue of $1.17 billion. The 65-page report provides an insight into the demographics and historical trend (2008-2013) of cancer incidences, deaths and prevalence along with statewide and site-wide cancer incidences in the United States.
The study dedicates a complete chapter on the various components of any proton therapy center and covers issues related to accelerators, delivery, transportation, planning and positioning systems to human resources required to setup a center.
The report further provides the statewide statistics of potential patients for proton therapy and the latter's current market penetration. It also includes a section dedicated to market opportunity assessment, which would help service providers and vendors to extract benefits from the largely untapped but lucrative market.
After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges that will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand and its probable transformation by 2017 for service providers and equipment vendors. Additionally, the report provides analyses of equipment vendors as well as their business overviews, products and services and existing and planned installations in the United States until 2017.
For more information: www.rncos.com
July 11, 2024 
